Edith M Hessel PhD

CSO and Immunologist; interested in ML and Agentic AI applied to Target and Drug Discovery, but above all in life and its colorful surprises

[Edith M Hessel PhD @HesselEdith]

A very warm welcome to the new CEO of the @britsocimm Graham Blair !@Grayblair101

[British Society for Immunology @britsocimm]

We’re delighted to announce that Graham Blair will be joining the BSI as our new Chief Executive, starting 3 Nov 2025 🎉

With a wealth of leadership experience, Graham will help us champion immunology & strengthen our community: https://t.co/VGwDmAar2R

[Lydia Becker Institute @LydiaBeckerIII]

🚨 A new £50M @The_MRC Centre at @FBMH_UoM and @UniofOxford will explore how pollution, microbes & other environmental exposures rewire our immune system and cause chronic inflammatory diseases.

https://t.co/1f5haD6Zrc

[Edith M Hessel PhD @HesselEdith]

Many congratulations to my teo colleagues, so well-deserved Prof Deborah Dunn-Walters @beecellnumbers and Prof Clare Bryant @ClareBryant13 🚀🚀

[British Society for Immunology @britsocimm]

🌟 BSI success stories!

Three of our members have been elected Fellows of the Academy of Medical Sciences 2025, including a BSI Trustee, Deborah - @beecellnumbers, whose leadership inspires the immunology community.

Read more about their achievements 👉 https://t.co/tWecxCaYg7

[Edith M Hessel PhD @HesselEdith]

Great work from the Zou Lab - a truly AI-designed molecule against S. aureus @james_y_zou #MRSA #AgenticAI

[James Zou @james_y_zou]

>700K people die each year due to S. aureus infection.

Today we show that our AI designed new molecule, synthecin, stops drug-resistant S. aureus MRSA in mouse model💊

We created synthecin w/ SyntheMol-RL, our new RL generative AI. All open source https://t.co/ll6EqP1KgZ

[Edith M Hessel PhD @HesselEdith]

@RelationRx in the news! Thoughtful report of our investor @DCVC @jason_pontin along with a review of biotech financing in the UK by the @BIA_UK

[Relation @RelationRx]

Thrilled to be featured in the @BIA_UK report on UK biotech financing and also highlighted in the @DCVC 2024 report.

➡️@DCVC report: TechBio and data-centric AI https://t.co/BjTconriLH
➡️ @BIA_UK 2024 report: https://t.co/GsjHuZX886

[BioIndustry Association (BIA) @BIA_UK]

🧬 @RelationRx partners with @GSK to tackle fibrotic #diseases and osteoarthritis – advancing drug discovery for millions in need ➡️ https://t.co/fiXKy2uWCL

Their cutting-edge platform and GSK’s expertise aim to deliver transformative #medicines.

[Edith M Hessel PhD @HesselEdith]

Incredibly delighted to be part of the Kennedy Trust Board. The high quality work and people funded by the trust paves the way to new therapeutic opportunities for patients! @TheKennedyTrust @KirOxford

[The Kennedy Trust for Rheumatology Research @TheKennedyTrust]

We’re delighted to welcome four new Trustees to the Kennedy Trust’s Board: Professor Paul Peter Tak @paulpetertak, Dr Edith Hessel @HesselEdith, Professor Paul Emery and Dr Tony Wood! Read more on our website 👇
https://t.co/xvDlwEkME5

[DCVC @DCVC]

In likely the largest deal ever for a seed-stage biotech/techbio company, @DCVC-backed @RelationRx and @GSK will seek to create a new gen of drugs for fibrotic disease and osteoarthritis. Big congrats to both companies!
More from DCVC GP @jason_pontin 👇
https://t.co/o18sbn84Kj

[Edith M Hessel PhD @HesselEdith]

Brilliant news! ⁦@RelationRx⁩ https://t.co/v7sOz67YrC

[Edith M Hessel PhD @HesselEdith]

Looking forward to seeing you @NeurIPSConf with my colleagues from @RelationRx Lindsay Edwards, Hagen Triendle, Anna Gogleva, and Rosie Rodriguez. @doctordindsay @TriendlHagenRel

[Bruno Trentini @brtrentini]

📅 Sunday, Dec 15th - From 14:15–15:00

NVIDIANs will join @doctordindsay and @HesselEdith from @RelationRx for an engaging panel discussion at the “AI for New Drug Modalities Workshop"

https://t.co/SoAl3C24uA

[Edith M Hessel PhD @HesselEdith]

Looking forward to Paul Peter’s keynote lecture today and the Immune Therapies Summit #ImmuneTherapies24 @britsocimm

[British Society for Immunology @britsocimm]

LAST CHANCE to secure reduced registration fees for BSI #ImmuneTherapies24 ⏰

This event will bring together #clinical, academic and #industry thought leaders including keynote speaker Dr @paulpetertak 🌟

Don't miss out! Register TODAY (31 Oct) 🔗https://t.co/mrdvMHtK53

[Relation @RelationRx]

Have you ever wondered which single cell/spatial omic technology to use? There's lots of methods developed in academia, but no review of marketed products.

Check the @scTrends_update (https://t.co/aEMejm8Upm) commentary in @NatureBiotech by @wildtypehuman & @AdamCribbs

[Edith M Hessel PhD @HesselEdith]

May is #OsteoporosisAwareness month. At @RelationRx, we use our Large Language Model & high dimensional patient data to shine a bright light on the mechanisms that underpin disease in these underserved patients. Our aim is to develop novel therapeutics. #ThePatientIsWaiting

[ASBMR @ASBMR]

Osteoporosis impacts millions of Americans. According to @bonehealthBHOF, one in two women and one in four men will break a bone due to osteoporosis. #OsteoporosisAwareness

[Edith M Hessel PhD @HesselEdith]

Many thanks @Emma_S_Chambers for an impactful 6 years of your time at the BSI Board, representing the Early Career Researchers along with Calum Bain @bainlab inviting us to consider new approaches to support those at the start of their careers in Immunology. #BSI

[Dr Emma S Chambers @Emma_S_Chambers]

Today is my last board meeting as @britsocimm trustee. I have spent six wonderful years representing ECRs - I am incredibly proud of ECR initiatives brought in by the BSI, such as the Career Enhancement Grants https://t.co/Kyzfp25wqD. Thanks to the trustees past and present.

[Bo Wang @BoWang87]

AI & Biology/medicine is at its best time 🔥🔥exciting time ahead!

[Edith M Hessel PhD @HesselEdith]

Many thanks to @anthonycosta for his excellent chairing. It was a great pleasure to be part of this panel at #GTC24, along with my co-panelist @NaefLuca @DaphneKoller and Gary Glick on behalf of @RelationRx.

[Zachary Carpenter, Ph.D. @zwcarpenter]

Stellar panel this morning at #GTC24 !

@NaefLuca representing @vant_ai, discussing the move from 2D to 3D data at cellular scale and our push into nano-scale engineering of protein circuits.

#nvidia #GTC24 #GTC

[Edith M Hessel PhD @HesselEdith]

Relation Therapeutics secures $35 million of new seed financing led by DCVC and co-lead NVentures, NVIDIA’s venture arm | BioSpace https://t.co/TUoT6h3q3A #jobs

[Edith M Hessel PhD @HesselEdith]

Relation Therapeutics secures $35 million of new seed financing led by DCVC and co-lead NVentures, NVIDIA’s venture arm https://t.co/mRBWFKDZ2I

[Charles Roberts @CCRobertsARK]

Interrogating LLMs for causal bio pathways may be a new frontier in discovering future cures.

Relation Tx (disclosure: I cofounded & chair) just announced an amazing syndicate of investors to complete the $60M Seed: DCVC, Deerfield, NVIDIA, Magnetic. EndPts exclusive below👇.

Hugely happy for the incredible team, and the visionary investors making this possible, incl. @zackbogue, @jason_pontin : @DCVC who led the new $35M to complete the Seed, Magnetic Ventures (led prior). New joiners @nvidia, plus Deerfield, one of the world's leading biotech investors, and Khosla, @vkhosla @genomicsdoc, also backers of OpenAI/ChatGPT.

Most all, excited for the potential to deliver previously impossible life-enhancing therapies to 🦴patients.

https://t.co/GYIFw4ld4I